ORALLY DELIVERED LIPID NANOPARTICLES TARGET AND REVEAL GUT CD36 AS A MASTER REGULATOR OF SYSTEMIC LIPID HOMEOSTASIS WITH DIFFERENTIAL GENDER RESPONSES
Disclosed herein are synthetic nanostructures, pharmaceutical compositions, kits, or methods for treating a wide spectrum of diseases associated with high fat diets or high saturated fat intake (e.g., cardiovascular disease, steatosis, cancer, diabetes type II, etc.). The synthetic nanostructures an...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Disclosed herein are synthetic nanostructures, pharmaceutical compositions, kits, or methods for treating a wide spectrum of diseases associated with high fat diets or high saturated fat intake (e.g., cardiovascular disease, steatosis, cancer, diabetes type II, etc.). The synthetic nanostructures and compositions are orally administered and target and act in the gut. |
---|